NasdaqCM - Nasdaq Real Time Price
USD
Akanda Corp. (AKAN)
3.3500
-0.3200
(-8.72%)
At close: September 4 at 4:00:01 PM EDT
3.4100
+0.0600
(+1.79%)
After hours: September 4 at 7:59:48 PM EDT
Loading chart for AKAN
- Previous Close
3.6700 - Open
4.3300 - Bid 3.2800 x 100
- Ask 4.2300 x 200
- Day's Range
3.2700 - 4.4400 - 52 Week Range
2.2973 - 209.2342 - Volume
21,453,982 - Avg. Volume
734,232 - Market Cap (intraday)
1.812M - Beta (5Y Monthly) 14.15
- PE Ratio (TTM)
-- - EPS (TTM)
-13,751.9297 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News
View More
Performance Overview
Trailing total returns as of 9/4/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
AKAN
67.45%
S&P 500 (^GSPC)
12.75%
1-Year Return
AKAN
95.80%
S&P 500 (^GSPC)
18.71%
3-Year Return
AKAN
99.89%
S&P 500 (^GSPC)
70.93%
5-Year Return
AKAN
100.00%
S&P 500 (^GSPC)
70.18%
Statistics
View MoreValuation Measures
As of 9/1/2026
-
Market Cap
2.02M
-
Enterprise Value
15.75M
-
Trailing P/E
0.02
-
Forward P/E
--
-
PEG Ratio (5yr expected)
--
-
Price/Sales (ttm)
0.04
-
Price/Book (mrq)
2.21
-
Enterprise Value/Revenue
61.03
-
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
-
Profit Margin
0.00%
-
Return on Assets (ttm)
-44.15%
-
Return on Equity (ttm)
--
-
Revenue (ttm)
258.07k
-
Net Income Avi to Common (ttm)
-46.16M
-
Diluted EPS (ttm)
-13,751.9297
Balance Sheet and Cash Flow
-
Total Cash (mrq)
503.56k
-
Total Debt/Equity (mrq)
--
-
Levered Free Cash Flow (ttm)
-5.71M
Compare
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
3.5000
+0.57%
Mkt Cap
2.048M
Industry
Drug Manufacturers—Specialty & Generic
2.2300
+1.36%
Mkt Cap
1.191M
Industry
Drug Manufacturers—Specialty & Generic
1.3800
+3.76%
Mkt Cap
7.368M
Industry
Drug Manufacturers—Specialty & Generic
0.9680
-1.14%
Mkt Cap
3.387M
Industry
Drug Manufacturers—Specialty & Generic
2.4200
-3.59%
Mkt Cap
3.652M
Industry
Drug Manufacturers—Specialty & Generic
3.2450
-0.15%
Mkt Cap
38.825M
Industry
Drug Manufacturers—Specialty & Generic
7.99
0.00%
Mkt Cap
32.183M
Industry
Drug Manufacturers—Specialty & Generic
Company Insights
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Learn more
Dividend Score
The distribution of earnings a company pays back to its shareholders based off the company’s profits. Usually paid out on a quarterly basis in the form of cash or additional stocks.
Hiring Score
A company’s hiring trends in key indicators can indicate how well the company is doing in terms of growing the company and where they are currently prioritizing.
Insider Sentiment Score
Vicker’s Insider Sentiment provides insights into trades made by insiders. This can be used to gain valuable insights and as a reflection of the prospect of the company based on insider trading.
